Contact
 

New Funding Opportunity: The Global Health Research Initiative and the Canadian HIV Vaccine Initiative launch a new program to build sustainable African capacity and leadership in clinical and prevention trials - July 30, 2009

The new program, which will focus on innovations in HIV prevention technologies, particularly HIV vaccines, offers a new funding opportunity for interested researchers. For more information, including the Letter Of Intent for this funding opportunity, please visit this link.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account